Navigating U.S.-India Trade Tensions
The United States has imposed tariffs of up to 50% on Indian exports, creating a potential advantage for international competitors. This theme focuses on companies that may capture market share from affected Indian industries and Indian firms in exempted sectors.
About This Group of Stocks
Our Expert Thinking
The U.S. has imposed tariffs of up to 50% on Indian exports worth $48.2 billion, creating significant market disruption. This presents a dual opportunity: international competitors may capture market share from affected Indian industries, whilst Indian companies in exempted sectors like pharmaceuticals and electronics remain shielded from the trade dispute.
What You Need to Know
This is an event-driven investment theme focused on geopolitical trade policy impacts. The tariffs particularly affect labour-intensive sectors like textiles and automobiles, whilst sparing key industries such as IT services and pharmaceuticals. This creates a mixed landscape of challenges and opportunities across different market segments.
Why These Stocks
These securities were carefully selected to capture both sides of this trade tension opportunity. The collection includes international companies positioned to benefit from reduced Indian competition in the U.S. market, alongside Indian firms operating within exempted sectors that remain protected from the tariff impacts.
Why You'll Want to Watch These Stocks
Strategic Market Shifts
Major trade policy changes create significant opportunities as markets realign. Companies positioned on the right side of these tariffs could see substantial competitive advantages emerge.
Protected Sector Advantage
Indian firms in exempted industries like pharmaceuticals and IT services remain shielded from trade tensions. This protection could make them increasingly attractive to investors seeking stability.
Global Competition Dynamics
With $48.2 billion worth of Indian exports facing steep tariffs, international competitors have a rare opportunity to capture significant U.S. market share in affected sectors.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Wireless Patent Stocks May Benefit in 2025
A significant jury verdict against Samsung for patent infringement highlights the immense value of wireless technology patents. This creates a potential investment opportunity in companies that own and license key intellectual property for 4G, 5G, and Wi-Fi communications.
Pharmaceutical Policy Shift Explained | Pricing Models
The Trump administration's recent drug pricing agreements with major pharmaceutical companies like AstraZeneca and Pfizer aim to lower U.S. drug costs by tying them to international prices. This creates a potential investment opportunity in pharmaceutical firms with strong domestic production and those in the healthcare supply chain that can adapt to the new pricing landscape.
Aviation Stocks: Spirit Crisis Creates Mixed Outlook
Spirit Airlines has secured court approval for crucial bankruptcy financing, signaling a major shake-up in the budget airline market. This development creates a potential opening for rival carriers to absorb market share and for aircraft lessors to renegotiate terms across the industry.
Frequently Asked Questions
Everything you need to know about the product and billing.